Experienced people for consequential R&D decisions.

Every engagement is owned by a named senior person with a defined outcome, a written scope and a clear decision boundary. We would rather turn down a poorly framed request than staff it with the wrong level of experience. Artificial intelligence is used internally to improve research speed, document consistency and traceability — never to manufacture authority or replace an accountable expert on a consequential decision.

California is home to one of the world’s largest concentrations of biotechnology, pharmaceutical and life-sciences activity, spanning the Bay Area, Los Angeles and San Diego. Being close to that density of R&D activity — and to the FDA-facing decisions it produces — shapes how RegulatoryX works: senior, hands-on, and comfortable moving between a start-up’s first IND and a later-stage registrational programme, backed by 15+ years of global drug-development and regulatory leadership.